Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair
NCT06100315Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jul 2023
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in postoperative pain, Emergence agitation (EA), sponsored by Assiut University. Started Jul 2023; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative painEmergence agitation (EA)
Beyond the preview
Go deeper on NCT06100315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06100315.